Jeff Musgnung, MS
- 6Articles
- 19.6KReads
- 2006–2015Active
- 39Collaborators
- 164Citations
About
Jeff Musgnung, MS, has contributed to Psychiatrist.com from 2006 to 2015, authoring six articles focused on major depressive disorder, posttraumatic stress disorder, and primary care psychiatry. His publications examine the efficacy, safety, and adverse events related to desvenlafaxine and venlafaxine treatments, including studies on prevention of recurrent depression and treatment responsiveness in PTSD. He has collaborated frequently with co-authors such as Philip T. Ninan, Susan G. Kornstein, Alan F. Schatzberg, Alan J. Gelenberg, and Anthony J. Rothschild.
Publications
Incidence and Timing of Taper/Posttherapy-Emergent Adverse Events Following Discontinuation of Desvenlafaxine 50 mg/d in Patients With Major Depressive Disorder
February 5, 2015
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
